Physician
Lakewood Urology Limited Liability Company
Lakewood Urology Limited Liability Company was paid $2.09M by Medicaid between Jan 2018 and Oct 2024, across 50 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 55% of everything it billed.
33Billing provider infoLAKEWOOD UROLOGY LIMITED LIABILITY COMPANY
HAMILTON, NJ 08690
HAMILTON, NJ 08690
33aNPI1356569388assigned 04/23/2007
33bProvider typeUrology Physician
28Total paid$2.09M
24GClaims41,271
24DCodes billed50
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Urology Physician providers in New Jersey
Rank by total paid#1 of 35
Median peer was paid$14K
This provider vs. median146×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,009 | $381K | |
| 2019 | 6,805 | $397K | |
| 2020 | 5,931 | $358K | |
| 2021 | 5,654 | $353K | |
| 2022 | 8,342 | $366K | |
| 2023 | 5,062 | $177K | |
| 2024incomplete | 2,468 | $60K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 55% | 16,856 | 15,051 | $1.15M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 8,765 | 7,710 | $345K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.5% | 1,249 | 1,189 | $157K |
| 88120 | 4.3% | 973 | 859 | $90K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.9% | 872 | 854 | $82K |
| 52000 | 3.8% | 457 | 449 | $79K | |
| 51741 | 2.3% | 1,236 | 1,210 | $49K | |
| 51798 | 1.2% | 2,640 | 2,475 | $26K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 457 | 439 | $20K |
| 50590 | <1% | 12 | 12 | $9K | |
| 99243 | <1% | 65 | 65 | $9K | |
| 99443 | <1% | 427 | 393 | $9K |
38 more codes
| 51728 | <1% | 25 | $7K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 191 | $7K |
| 81002 | <1% | 2,215 | $7K | |
| 99223 | Prolong inpt eval add15 m | <1% | 64 | $7K |
| 51797 | <1% | 25 | $6K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 26 | $5K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 144 | $5K |
| 45990 | <1% | 75 | $4K | |
| 52281 | <1% | 12 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 22 | $3K |
| 99205 | Prolong outpt/office vis | <1% | 15 | $2K |
| 51784 | <1% | 25 | $2K | |
| 88112 | <1% | 1,037 | $2K | |
| 95972 | <1% | 14 | $919.93 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 129 | $533.76 |
| 88313 | <1% | 191 | $492.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 42 | $484.94 |
| 36000 | <1% | 287 | $368.85 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 128 | $246.37 |
| 76000 | <1% | 19 | $101.30 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 96 | $84.74 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 105 | $80.32 |
| 74018 | <1% | 13 | $44.07 | |
| 87500 | <1% | 128 | $41.07 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 46 | $12.90 |
| 87641 | <1% | 130 | $6.32 | |
| 87481 | <1% | 116 | $6.32 | |
| 87640 | <1% | 130 | $6.32 | |
| 87653 | <1% | 116 | $3.16 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 1,046 | $1.00 |
| G9905 | Patient not screened for tobacco use | 0% | 13 | $0.00 |
| G0029 | Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period | 0% | 14 | $0.00 |
| 87150 | 0% | 14 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 186 | $0.00 |
| 1036F | 0% | 174 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 111 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 125 | $0.00 |
| 1123F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAZI, MUKARAM (OWNER)